Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel anticancer agents imparted in recent Novartis patent

Feb. 15, 2007

Novel tubulin polymerization inhibitors identified at Threshold Pharmaceuticals

Feb. 15, 2007

Ariad grants commercial license to Argent technology to CellNexus

Feb. 14, 2007

Micromet exercises option for Morphotek antibody

Feb. 14, 2007

PEP-005 Topical studied in phase II trial for superficial BCC

Feb. 14, 2007

SIR-Spheres, bevacizumab + chemotherapy studied for metastatic colorectal cancer

Feb. 14, 2007

Nexavar extends survival in advanced hepatocellular carcinoma

Feb. 13, 2007

ViaCell will not advance CB-001 based on phase I findings

Feb. 13, 2007

Apotherapy CD40 research program receives E.U. funding

Feb. 13, 2007

Guidelines devised for photodynamic therapy for nonmelanoma skin cancer

Feb. 13, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.